Long COVID: Targeting Immune Cells for Lung Repair

Friday, 6 September 2024, 09:02

Long COVID can inflict deep scars on the lungs, but targeting specific immune cells may reverse this damage. New research conducted in mice reveals insights into immune responses that could offer therapeutic avenues for patients suffering from long COVID.
LivaRava_Medicine_Default.png
Long COVID: Targeting Immune Cells for Lung Repair

The Impact of Long COVID on Lung Health

Long COVID poses significant challenges, particularly concerning the lungs. Recent studies show that patients infected with COVID-19 experience lingering effects, including lung damage. Researchers examined lung samples from these individuals and discovered an overactive immune response correlated with extensive scarring.

Targeting Immune Cells: A New Approach

In exciting new research involving mice, scientists have identified specific immune cells that, when targeted, could potentially reverse lung fibrosis caused by long COVID. By modulating these immune responses, therapies may emerge to mitigate the effects of long COVID more effectively.

  • Recovery of lung function
  • Long-term treatment implications
  • Possibility for new therapeutics

This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.


Related posts


Newsletter

Subscribe to our newsletter for the most accurate and current medical news. Stay updated and deepen your understanding of medical advancements effortlessly.

Subscribe